Results 61 to 70 of about 102,263 (291)

Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): A randomised controlled trial. [PDF]

open access: yes, 2020
BACKGROUND: The early use of broad-spectrum antibiotics remains the cornerstone for the treatment of neonatal late onset sepsis (LOS). However, which antibiotics should be used is still debatable, as relevant studies were conducted more than 20 years ago,
Aboulker, J-P   +30 more
core   +3 more sources

Detección fenotípica de metalobetalactamasas en aislados clínicos de Pseudomonas aeruginosa

open access: yesKasmera, 2012
: Pseudomonas aeruginosa is considered one of the most important hospital germs; its isolation is common in hospitalized patients. In addition, this microorganism has a marked multiresistance, which increases mortality.
Perozo-Mena Armindo José   +3 more
doaj  

Epidemiology of antibiotic resistance in culture-positive hospitalized patients in selected hospitals in Khartoum, Sudan [PDF]

open access: yes, 2019
Objective: To study the prevelence of antibiotic resistance and the prevalent bacterial isolates in hospitalized patients in Khartoum hospitals. Materials & Methods: A cross-sectional prevalence study was carried out during the period of April ...
Abdalrahman, Ihab B   +3 more
core   +4 more sources

Atypical Wounds in Chronic Graft‐Versus‐Host Disease and Peripheral Arterial Disease Caused by Tyrosine Kinase Inhibitors

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT The term “atypical wounds” primarily refers to lesions with immunological or cancerous etiologies. However, these wounds can also be drug‐induced. We report about a 32‐year‐old man with a 6‐year history of chronic myelogenous leukemia (CML) and chronic graft‐versus‐host disease (cGvHD) following an HLA‐compatible allogeneic stem cell ...
E. K. Stuermer   +3 more
wiley   +1 more source

Do We Need Meropenem Treatment Beyond 7 Days in Febrile Neutropenic Patients: A Cost-Effectiveness Analysis

open access: yesAntibiotics
Background: Febrile neutropenia is a critical complication in patients with hematological malignancies; immediate initiation of empirical treatment with a broad-spectrum agent is the standard of care.
Leyla Yumrukaya   +6 more
doaj   +1 more source

Successful Treatment Using Apixaban in a Patient on Hemodialysis with Uremic Calciphylaxis

open access: yesClinical, Cosmetic and Investigational Dermatology, 2022
Moudi M Alasmari,1,2 Mona Y Alsheikh,3 Hend H Metwali2,4 1College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; 2King Abdullah International Medical Research Centre, Jeddah, Saudi Arabia; 3School of Pharmacy ...
Alasmari MM, Alsheikh MY, Metwali HH
doaj  

The Case for Intermittent Carbapenem Dosing in Stable Haemodialysis Patients

open access: yesAntibiotics, 2020
Purpose: Antimicrobial resistant infections are common in patients on haemodialysis, often needing long courses of carbapenems. This results in a longer hospital stay and risk of iatrogenic complications.
Vanda Ho   +4 more
doaj   +1 more source

Comparative transcriptomics of multidrug-resistant Acinetobacter baumannii in response to antibiotic treatments [PDF]

open access: yes, 2018
Multidrug-resistant Acinetobacter baumannii, a major hospital-acquired pathogen, is a serious health threat and poses a great challenge to healthcare providers.
Chan, Ting-Fung   +8 more
core   +2 more sources

Meropenem

open access: yesRevista de Medicina de la Universidad de Navarra, 2017
M, Escolar, J, Honorato
  +6 more sources

In Vitro Evaluation of Antimicrobial Synergy Against Multidrug-Resistant Gram-Negative Paediatric Bloodstream Pathogens in South Africa

open access: yesAntibiotics
Background: In vitro synergy testing (ST) is a useful means to gauge the performance ofantibiotic combinations against multidrug-resistant (MDR) Gram-negative bacteria (GNB).
Prenika Jaglal   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy